Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Cookie-PrferenzenGesetz ber digitale DiensteDatenschutzerklrungAGBImpressumWiderrufsrechtEU-BehrdenNutzungsbedingungen
Climacteric 17 , 308309 (2014)
Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
Beauty extends beyond the skin
It would not be correct to make a definitive recommendation for a specific nutritional intervention
US$ 24.05
US$ 23.62
US$ 26.29
US$ 24.61
US$ 22.54
US$ 20.27
US$ 21.43
US$ 28.62
US$ 26.56
US$ 25.17
US$ 23.87
